Manage Fascial Closure For Better Patient Outcomes
AbClo minimizes complications by promoting early aggressive closure, via non-invasive traction
Achieve a 98% primary fascial closure on intentionally left-open abdomens
When a patient requires open abdomen treatment, facilitating early
aggressive closure without increasing complications is crucial.
aggressive closure without increasing complications is crucial.
Prompt and safe prevention of fascial retraction and negative
pressure wound therapy can improve outcomes.
Non-Invasive & 100% Compatible with AbThera
Guidelines show that prompt and safe prevention of fascial traction device.
Preventative Care for Fascial Damage and Closure Complications
Reduce the risk of infections, fistulas, and hernias by preventing fascial retraction.
Your Patients Are Our Priority
Our surgical innovations aim to find better ways to improve patient outcomes and save precious time and resources.
Testimonials
We saw positive patient impacts almost immediately once we began using the AbClo. In addition, we save considerable hard and soft costs and our physicians enjoyed using the AbClo device. Using the AbClo is not only improving our patient care but freeing up significant resources when we need them the most.
The AbClo device resulted in a primary myofascial closure rate of 98%. Our findings suggest that a non-invasive, preemptive, approach to fascial reapproximation could have a positive impact in preventing lateralization and contraction of the abdominal wall in OA patients.
AbClo dramatically improved our closure rate for open abdomen patients. It was easy to use and was easily integrated into my current treatment methods for open abdomen patients. AbClo’s use resulted in better outcomes for my patients.
AbClo has provided us with an important additional non-invasive approach to aggressive facial closure for our OA cases in our trauma service. Our ability to manage the reapproximation of the OA cases is a significant advantage that may avoid using more invasive alternative devices that are currently available.
AbClo allowed us to successfully close when we needed.
The AbClo device proved invaluable for our patient with an open abdomen receiving Direct
Peritoneal Dialysis. Even after the patient required CPR, the AbClo helped maintain pressure and
ensure the seal remained intact once we regained ROSC. It's a reliable tool in critical situations.
In my experience, patients do better and heal quicker with an AbClo device. It's become an
essential part of our treatment protocol for managing trauma patients with open abdomens.
The AbClo device is a game-changer. Patients consistently have good outcomes. What's really
impressive is how it helps fascia on larger patients close faster. It's made a significant difference
in our practice and patient care.
Minimize Closure Complications,
Optimize Patient Recovery
Our fascial traction system offers improved patient outcomes, reduced
recovery time, lower healthcare costs, and meets EAST guidelines for optimal abdominal management.
recovery time, lower healthcare costs, and meets EAST guidelines for optimal abdominal management.
Why AbClo?
Non-invasively manage and promote closure of open abdomen with our FDA and Health Canada Licensed Device.
Easy to Apply
Our intuitive device is easy to use and can be managed at the patient’s bedside. It integrates easily into existing care paths and procedures.
Better Patient Experience
We prioritize patient experience by providing a non-invasive solution that minimizes additional skin damage and complications.
Increase Hospital Efficiency
AbClo streamlines the treatment process, saving time and resources while delivering optimal results.
Insights
Latest News
Explore the most recent developments and advancements with AbClo.
CONTACT US
Critical Innovations in Surgery
Our goal of our surgical innovations is to find better ways to improve patient outcomes and also make it easier on the medical teams and hospitals. Our innovations save precious time and lives.